FR1759M - - Google Patents

Download PDF

Info

Publication number
FR1759M
FR1759M FR888884A FR888884A FR1759M FR 1759 M FR1759 M FR 1759M FR 888884 A FR888884 A FR 888884A FR 888884 A FR888884 A FR 888884A FR 1759 M FR1759 M FR 1759M
Authority
FR
France
Prior art keywords
caffeine
acetyl
acetyl tryptophanate
effect
tryptophanate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR888884A
Other languages
English (en)
French (fr)
Inventor
Yves Barre
Jean Molle
Maurice Vigneron
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Adisseo France SAS
Original Assignee
AEC Societe de Chimie Organique and Biologique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AEC Societe de Chimie Organique and Biologique SA filed Critical AEC Societe de Chimie Organique and Biologique SA
Priority to US25972463 priority Critical patent/US3247203A/en
Priority to FR888884A priority patent/FR1759M/fr
Priority to CH192363A priority patent/CH408946A/fr
Priority to BE628521A priority patent/BE628521A/fr
Priority to GB6397/63A priority patent/GB991306A/en
Priority to DK80563AA priority patent/DK119981B/da
Priority to DEA42386A priority patent/DE1215719B/de
Priority to ES285353A priority patent/ES285353A1/es
Application granted granted Critical
Publication of FR1759M publication Critical patent/FR1759M/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/12—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1, 3, and 7, e.g. caffeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Fodder In General (AREA)
FR888884A 1962-02-22 1962-02-22 Expired FR1759M (US07217764-20070515-C00014.png)

Priority Applications (8)

Application Number Priority Date Filing Date Title
US25972463 US3247203A (en) 1962-02-22 1962-02-22 Caffeine acetyl tryptophanate
FR888884A FR1759M (US07217764-20070515-C00014.png) 1962-02-22 1962-02-22
CH192363A CH408946A (fr) 1962-02-22 1963-02-15 Procédé de préparation d'acétyltryptophanate de caféine
BE628521A BE628521A (US07217764-20070515-C00014.png) 1962-02-22 1963-02-15
GB6397/63A GB991306A (en) 1962-02-22 1963-02-18 Caffeine acetyl tryptophanate and its process of preparation
DK80563AA DK119981B (da) 1962-02-22 1963-02-21 Fremgangsmåde til fremstilling af coffeinacetyltryptophanat.
DEA42386A DE1215719B (de) 1962-02-22 1963-02-21 Verfahren zur Herstellung einer Molekuelverbindung des Coffeins
ES285353A ES285353A1 (es) 1962-02-22 1963-02-22 Procedimiento de preparación de acetil triftofanato de cafeína

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR888884A FR1759M (US07217764-20070515-C00014.png) 1962-02-22 1962-02-22

Publications (1)

Publication Number Publication Date
FR1759M true FR1759M (US07217764-20070515-C00014.png) 1963-05-03

Family

ID=8773273

Family Applications (1)

Application Number Title Priority Date Filing Date
FR888884A Expired FR1759M (US07217764-20070515-C00014.png) 1962-02-22 1962-02-22

Country Status (8)

Country Link
US (1) US3247203A (US07217764-20070515-C00014.png)
BE (1) BE628521A (US07217764-20070515-C00014.png)
CH (1) CH408946A (US07217764-20070515-C00014.png)
DE (1) DE1215719B (US07217764-20070515-C00014.png)
DK (1) DK119981B (US07217764-20070515-C00014.png)
ES (1) ES285353A1 (US07217764-20070515-C00014.png)
FR (1) FR1759M (US07217764-20070515-C00014.png)
GB (1) GB991306A (US07217764-20070515-C00014.png)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4406903A (en) * 1981-01-21 1983-09-27 John Wyeth And Brother Limited Xanthine derivatives useful as antidepressives
CN1968691B (zh) * 2004-04-19 2010-12-29 麒麟麦酒株式会社 用于通过葡糖异生作用加速酒精代谢或从疲劳恢复的组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL84498C (US07217764-20070515-C00014.png) * 1936-10-28
US2185219A (en) * 1937-04-13 1940-01-02 Smith Kline French Lab Furfuryl n-morpholine alkyl halide medicinal preparation
DE694822C (de) * 1937-11-25 1940-08-08 Byk Guldenwerke Chem Fab Akt G Verfahren zur Herstellung wasserloeslicher Doppelverbindungen von Purinen
US2688618A (en) * 1952-01-03 1954-09-07 Bristol Lab Inc Basic caffeine derivatives
US2700667A (en) * 1952-01-03 1955-01-25 Bristol Lab Inc 8-(2-benzyl-4-chlorophenoxy) caffeine
GB790557A (en) * 1955-05-09 1958-02-12 Ward Blenkinsop & Co Ltd Piperazine derivatives
US2961377A (en) * 1957-08-05 1960-11-22 Us Vitamin Pharm Corp Oral anti-diabetic compositions and methods
FR1216136A (fr) * 1959-01-30 1960-04-22 Cherifienne D Etudes Et De Rec Procédé de solubilisation de certaines bases puriques et pyrimidiques
US3094537A (en) * 1961-05-01 1963-06-18 Dow Chemical Co Resolution of acetyl-di-tryptophan

Also Published As

Publication number Publication date
GB991306A (en) 1965-05-05
ES285353A1 (es) 1963-08-01
DE1215719B (de) 1966-05-05
CH408946A (fr) 1966-03-15
DK119981B (da) 1971-03-22
BE628521A (US07217764-20070515-C00014.png) 1963-05-29
US3247203A (en) 1966-04-19

Similar Documents

Publication Publication Date Title
Tolosa et al. Meige disease: striatal dopaminergic preponderance
DE69233462T2 (de) Zusammensetzung die Tramadol und ein nichtsteroides entzündungshemmenden Mittel enthält
FR2468368A1 (fr) Agent pour le traitement de theilerioses a base de quinazolinone
BE834794A (fr) Acide 3-trihydroxygermano-propionique
TW200808743A (en) Compositions and methods of treating CNS disorders
US20230157976A1 (en) Hexylamine salts and methods of using hexylamine
FR2530468A1 (fr) Composition analgesique et anti-inflammatoire contenant de l'ibuprofen
Brogden et al. Levodopa: A review of its pharmacological properties and therapeutic uses with particular reference to Parkinsonism
Sögaard et al. The effect of orally administered chlorpromazine on the electroencephalogram of man
FR1759M (US07217764-20070515-C00014.png)
FR2684552A1 (fr) Utilisation de la d-fenfluramine et de derives de la fenfluramine dans le traitement de l'hypertension chez des sujets insulino-resistants.
WO1991002725A1 (fr) Derives de la 5-amino-1,2,3,4-tetrahydro-acridine et applications comme medicaments
Straker Imipramine (tofranil): a safe, effective antidepressant drug in private practice
BE1003959A5 (fr) Agent therapeutique pour le traitement de troubles associes a l'ischemie cerebrale.
JPS6081127A (ja) 食欲抑制剤
DE2841170A1 (de) Hypnotikum
EP4045058A1 (fr) Utilisation de nictotinamide mononucléotide (nmn) pour la prevention et/ou le traitement de la polyarthrite rhumatoïde et compositions correspondantes
US3065136A (en) Treatment of vascular diseases with 2-aminoethanol-1-nitrate salt of p-toluene sulfonic acid
Crane et al. Psychotropic Drugs and Dysfunctions of the Basal Ganglia: A Multidisciplinary Workshop: Proceedings of a Workshop Held in Bethesda, Maryland, October 31-Nobember 2, 1968
TWI325317B (en) Appetite-stimulating agents and remedies for anorexia
FR2512673A1 (fr) Sels physiologiquement acceptables de l'acide g-butyrolactone-g-carbonyl-histidyl-prolinamide, ayant des proprietes anti-epileptiques
EP0707477A1 (fr) Utilisation de l'efaroxan et de ses derives pour la fabrication de medicaments destines au traitement des maladies neurodegeneratives
FR2391M (US07217764-20070515-C00014.png)
BE557985A (US07217764-20070515-C00014.png)
SU741876A1 (ru) Средство дл лечени нервно-психических заболеваний